novel precision drugs that target the tumor microenvironment
Diagnostic tests that analyse stromal biomarkers, to diagnose and prognose tumor invasiveness
Novel stroma-targeted precision drugs, to fight against invasive tumors
INVASIVE CANCER DIAGNOSTICS
ONCOMATRYX scientists have discovered and validated novel stromal biomarkers for accurate diagnosis and prognosis of invasive tumors.